COVID-19 triggering new diabetes to be tracked in a new global CoviDiab registry

L-R: Profs Stephanie Amiel and Francesco Rubino of Kings
 College London, and Prof Paul Zimmet, Monash University

Emerging evidence suggests that COVID-19 may actually trigger the onset of diabetes in healthy people and also cause severe complications of pre-existing diabetes.

A letter published 13 June in the New England Journal of Medicine and signed by an international group of 17 leading diabetes experts involved in the CoviDiab project, a collaborative international research initiative - including Monash University Professor of Diabetes Paul Zimmet - announces the establishment of a Global Registry of new cases of diabetes in patients with COVID-19.

Advances in treatment for patients with thyroid cancer

Pictured, Professor Jonathan Serpell, whose speciality is the thyroid, examining a patient.  Prof Serpell and the Monash University Endocrine Surgery Unit have developed a thyroid cancer registry resulting in advances in treatment for patients with thyroid cancer. Research into monitoring of recurrent laryngeal nerve function during thyroidectomy has demonstrated several important findings including: that split nerves occur in 23% of cases;

Multiple Myeloma blood cancer registry

A multiple myeloma blood cancer registry, the first of its kind in Australia and New Zealand, is being piloted through the Alfred in conjunction with Monash University. Professor Andrew Spencer, Head of the ACBD Myeloma research group investigating malignant haematology and and stem cell transplantation, said that the registry was developed after a realisation that there were no correct data on myeloma in Australia,